Biotech Values

[jbog]

Mon- I've never been in favor of a company borrowing money to finance the purchase of shares.

It reminds me more of buying stock on margin. Is the price right, only time will tell.

The value of the transaction amounts to around $21 per share, would you just as soon receive a $21 per share dividend? The future cost of the transaction far exceeds the dividend cost so how much does the buyback really cost.

This transaction seems as a cover-up for a poor quarterly report.

I find it funny that you laugh when Teva or anyone else gives a long term projection and yet it's like concrete when one of the companies you're bullish on give a prediction. My last post proves their predictions are useless.